Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in veterans: Role of vitamin D deficiency

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 3, 2012, Pages 281-286

  Youssef, D ^a   Bailey, B ^a   El Abbassi, A ^a   Vannoy, M ^b   Manning, T ^b   Moorman, J P ^a,b   Peiris, A N ^a,b  

^a East Tennessee State University   (United States)

^b James H Quillen VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PSEUDOMONAS PNEUMONIA; RETROSPECTIVE STUDY; UNITED STATES; VETERAN; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CALCIFEDIOL; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; VETERANS; VITAMIN D DEFICIENCY;

EID: 84857063275     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1308-9     Document Type: Article

References (64)

1. MF Holick 2008 The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action Mol Aspects Med 29 361 368 18801384 10.1016/j.mam.2008.08.008 1:CAS:528:DC%2BD1cXhtlyiur3I
2. AN Peiris BA Bailey T Manning 2008 The relationship of vitamin D deficiency to health care costs in veterans Mil Med 173 1214 1218 19149342
3. DL Kamen V Tangpricha 2010 Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity J Mol Med 88 441 450 20119827 10.1007/s00109-010-0590-9 1:CAS:528:DC%2BC3cXlt1aiu74%3D
4. L Jeng AV Yamshchikov SE Judd HM Blumberg GS Martin TR Ziegler V Tangpricha 2009 Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis J Transl Med 7 28 19389235 10.1186/1479-5876-7-28
5. AA Ginde JM Mansbach CA Camargo Jr 2009 Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey Arch Intern Med 169 384 390 19237723 10.1001/archinternmed.2008.560 1:CAS:528:DC%2BD1MXjsVKnsbY%3D
6. Y Shapira N Agmon-Levin Y Shoenfeld 2010 Mycobacterium tuberculosis, autoimmunity, and vitamin D Clin Rev Allergy Immunol 38 169 177 19543859 10.1007/s12016-009-8150-1 1:CAS:528:DC%2BC3cXktVCgurc%3D
7. JJ Cannell R Vieth JC Umhau MF Holick WB Grant S Madronich CF Garland E Giovannucci 2006 Epidemic influenza and vitamin D Epidemiol Infect 134 1129 1140 16959053 10.1017/S0950268806007175 1:CAS:528:DC%2BD28XhtFWns7rJ (Pubitemid 44614932)
8. E Bonilla 1954 Treatment of chromoblastomycosis with calciferol; report of three cases AMA Arch Derm Syphilol 70 666 667 13206410 1:STN:280: DyaG2M%2FhvVSntQ%3D%3D
9. EM Matheson AG Mainous III WJ Hueston VA Diaz CJ Everett 2010 Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage Scand J Infect Dis 42 455 460 20210515 10.3109/00365541003602049 1:CAS:528:DC%2BC3cXntVagu7s%3D
10. AL Panlilio DH Culver RP Gaynes S Banerjee TS Henderson JS Tolson WJ Martone 1992 Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991 Infect Control Hosp Epidemiol 13 582 586 1469266 10.1086/646432 1:STN:280:DyaK3s7gslKgtA%3D%3D
11. AF Shorr ST Micek MH Kollef 2008 Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications Crit Care Med 36 2335 2340 18596624 10.1097/CCM.0b013e31818103ea 1:CAS:528:DC%2BD1cXptFSmsbs%3D
12. RJ Rubin CA Harrington A Poon K Dietrich JA Greene A Moiduddin 1999 The economic impact of Staphylococcus aureus infection in New York City hospitals Emerg Infect Dis 5 9 17 10081667 10.3201/eid0501.990102 1:STN:280: DyaK1M7otFGjug%3D%3D (Pubitemid 29124770)
13. EM Graffunder RA Venezia 2002 Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials J Antimicrob Chemother 49 999 1005 12039892 10.1093/jac/dkf009 1:CAS:528:DC%2BD38XltVyrtr8%3D (Pubitemid 34692894)
14. TA Madani 2002 Epidemiology and clinical features of methicillin- resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia Can J Infect Dis 13 245 250 18159397
15. T Kim PI Oh AE Simor 2001 The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals Infect Control Hosp Epidemiol 22 99 104 11232886 10.1086/501871 1:STN:280:DC%2BD3M3gsVektA%3D%3D (Pubitemid 32157160)
16. ST Micek AE Lloyd DJ Ritchie RM Reichley VJ Fraser MH Kollef 2005 Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment Antimicrob Agents Chemother 49 1306 1311 15793102 10.1128/AAC.49.4.1306-1311.2005 1:CAS:528:DC%2BD2MXjt1Gjsr4%3D (Pubitemid 40463352)
17. AD Armour HA Shankowsky T Swanson J Lee EE Tredget 2007 The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit J Trauma 63 164 171 17622885 10.1097/01.ta.0000240175.18189.af (Pubitemid 47057580)
18. PM Arnow EM Quimosing M Beach 1993 Consequences of intravascular catheter sepsis Clin Infect Dis 16 778 784 8329510 10.1093/clind/16.6.778 1:STN:280:DyaK3szitVWqsw%3D%3D (Pubitemid 23157981)
19. GH Talbot J Bradley JE Edwards Jr D Gilbert M Scheld JG Bartlett 2006 Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America Clin Infect Dis 42 657 668 16447111 10.1086/499819 (Pubitemid 43271379)
20. G Braccini F Festini V Boni AS Neri V Galici S Campana L Zavataro F Trevisan C Braggion G Taccetti 2009 The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients J Chemother 21 188 192 19423472 1:CAS:528:DC%2BD1MXmsVeqs78%3D
21. KJ Eagye DP Nicolau JL Kuti 2009 Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia Semin Respir Crit Care Med 30 116 123 19199193 10.1055/s-0028-1119815
22. R Bou L Lorente A Aguilar J Perpiñán P Ramos M Peris D Gonzalez 2009 Hospital economic impact of an outbreak of Pseudomonas aeruginosa infections J Hosp Infect 71 138 142 18799237 10.1016/j.jhin.2008.07.018 1:STN:280:DC%2BD1M%2Fos1yjtw%3D%3D
23. E Tacconelli M Tumbarello S Bertagnolio R Citton T Spanu G Fadda R Cauda 2002 Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology Emerg Infect Dis 8 220 221 11897080 10.3201/eid0802.010121 (Pubitemid 34202451)
24. A Harris C Torres-Viera L Venkataraman P DeGirolami M Samore Y Carmeli 1999 Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa Clin Infect Dis 28 1128 1133 10452647 10.1086/514760 1:STN:280:DyaK1MznvFOitA%3D%3D (Pubitemid 29203551)
25. Y Carmeli N Troillet AW Karchmer MH Samore 1999 Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa Arch Intern Med 159 1127 1132 10335691 10.1001/archinte.159.10.1127 1:STN:280:DyaK1M3ms1OhsA%3D%3D (Pubitemid 29230866)
26. S Osmon S Ward VJ Fraser MH Kollef 2004 Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa Chest 125 607 616 14769745 10.1378/chest.125.2.607 (Pubitemid 38223643)
27. JM Streit RN Jones HS Sader TR Fritsche 2004 Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001) Int J Antimicrob Agents 24 111 118 15288308 10.1016/j. ijantimicag.2003.12.019 1:CAS:528:DC%2BD2cXmt1WgsLw%3D (Pubitemid 38993688)
28. VIReC Research User Guide (2004) VHA DSS clinical national data extracts FY2000-FY2004. Veterans Affairs Information Resource Center, Hines, IL, revised August 2005
29. RH Napier LS Bruelheide ET Demann RH Haug 2008 Insurance billing and coding Dent Clin North Am 52 507 527 18501731 10.1016/j.cden.2008.02.008 viii
30. SM Banajeh 2009 Nutritional rickets and vitamin D deficiency-association with the outcomes of childhood very severe pneumonia: a prospective cohort study Pediatr Pulmonol 44 1207 1215 19911367 10.1002/ppul.21121
31. S Manaseki-Holland G Qader M Isaq Masher J Bruce M Zulf Mughal D Chandramohan G Walraven 2010 Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial Trop Med Int Health 15 1148 1155 20723187 10.1111/j.1365-3156.2010.02578.x 1:CAS:528:DC%2BC3cXht12mtr3J
32. E Feindt J Stroder 1977 Studies on the antimicrobial effect of vitamin D (author's transl) Klin Wochenschr 55 507 508 195120 10.1007/BF01489010 1:CAS:528:DyaE2sXkvFKks7o%3D (Pubitemid 8085569)
33. GR Huff WE Huff JM Balog NC Rath H Xie RL Horst 2002 Effect of dietary supplementation with vitamin D metabolites in an experimental model of turkey osteomyelitis complex Poult Sci 81 958 965 12162356 1:CAS:528: DC%2BD38XmtVCltLs%3D (Pubitemid 39622711)
34. B Islam SN Khan AU Khan 2007 Dental caries: from infection to prevention Med Sci Monit 13 RA196 RA203 17968308
35. MS de la Torre C Torres G Nieto S Vergara AJ Carrero J Macías JA Pineda A Caruz J Fibla 2008 Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users J Infect Dis 197 405 410 18205531 10.1086/525043 (Pubitemid 351263422)
36. JH Li DM Chen Z Li Y Liu JR Gao XJ Zeng CF Zhong XL Zhu CY Gou L Pan J Shan XH Guo H Li 2006 Study on association between vitamin D receptor gene polymorphisms and the outcomes of HBV infection Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23 402 405 16883526 1:CAS:528:DC%2BD2sXhtFejsrzI (Pubitemid 44272022)
37. M Yano M Ikeda K Abe H Dansako S Ohkoshi Y Aoyagi N Kato 2007 Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture Antimicrob Agents Chemother 51 2016 2027 17420205 10.1128/AAC.01426-06 1:CAS:528:DC%2BD2sXmtlKrs70%3D (Pubitemid 46903089)
38. JH Beigel J Farrar AM Han FG Hayden R Hyer MD de Jong S Lochindarat TK Nguyen TH Nguyen TH Tran A Nicoll S Touch KY Yuen Writing Committee of the World Health Organization (WHO) 2005 Consultation on human influenza A/H5: Avian influenza A (H5N1) infection in humans N Engl J Med 353 1374 1385 16192482 10.1056/NEJMra052211 (Pubitemid 41362705)
39. N Talat S Perry J Parsonnet G Dawood R Hussain 2010 Vitamin d deficiency and tuberculosis progression Emerg Infect Dis 16 853 855 20409383 1:CAS:528:DC%2BC3cXmsFyltLc%3D
40. MT Cantorna S Yu D Bruce 2008 The paradoxical effects of vitamin D on type 1 mediated immunity Mol Aspects Med 29 369 375 18561994 10.1016/j.mam.2008.04.004 1:CAS:528:DC%2BD1cXhtlyiur3J
41. JJ Murray CR Heim 1985 Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D Am J Med 78 881 884 3993669 10.1016/0002-9343(85)90300- 6 1:STN:280:DyaL2M7ps1ahtg%3D%3D (Pubitemid 15008248)
42. HJ Vial MJ Thuet JR Philippot 1982 Inhibition of the in vitro growth of Plasmodium falciparum by D vitamins and vitamin D-3 derivatives Mol Biochem Parasitol 5 189 198 6283344 10.1016/0166-6851(82)90020-2 1:CAS:528: DyaL38XitFKmsro%3D
43. A Olsen FW Thiong'o JH Ouma D Mwaniki P Magnussen KF Michaelsen H Friis PW Geissler 2003 Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren Trans R Soc Trop Med Hyg 97 109 114 12886816 10.1016/S0035-9203(03)90042-3 1:CAS:528:DC%2BD3sXmslaks7g%3D (Pubitemid 36874059)
44. N Chowdhury 1978 Effects of fat soluble vitamins (vitamin A, D3 and E) on axenically in vitro growth of Hymenolepis microstoma Z Parasitenkd 56 29 38 212890 10.1007/BF00925934 1:CAS:528:DyaE1cXls1WqtLs%3D (Pubitemid 9005461)
45. CM Veldman MT Cantorna HF DeLuca 2000 Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system Arch Biochem Biophys 374 334 338 10666315 10.1006/abbi.1999.1605 1:CAS:528:DC%2BD3cXpsVagtA%3D%3D (Pubitemid 30120270)
46. F Lorente G Fontan P Jara C Casas MC Garcia-Rodriguez JA Ojeda 1976 Defective neutrophil motility in hypovitaminosis D rickets Acta Paediatr Scand 65 695 699 187003 1:STN:280:DyaE2s%2Fmt1ekuw%3D%3D
47. J Schauber RA Dorschner K Yamasaki B Brouha RL Gallo 2006 Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli Immunology 118 509 519 16895558 1:CAS:528:DC%2BD28XovFyhtrw%3D (Pubitemid 44079569)
48. AF Gombart N Borregaard HP Koeffler 2005 Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3 FASEB J 19 1067 1077 15985530 10.1096/fj.04-3284com 1:CAS:528:DC%2BD2MXlvVCht78%3D (Pubitemid 40946432)
49. JM Mata-Granados J Vargas-Vasserot C Ferreiro-Vera Luque de Castro MD RG Pavón JM Quesada Gómez 2010 Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method J Steroid Biochem Mol Biol 121 452 455 20399267 10.1016/j.jsbmb.2010.03.078 1:CAS:528:DC%2BC3cXptVGjtr8%3D
50. T Pincikova K Nilsson IE Moen F Karpati G Fluge A Hollsing PK Knudsen A Lindblad L Mared T Pressler L Hjelte 2011 Scandinavian cystic fibrosis study consortium: inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional study Eur J Clin Nutr 65 102 109 20859300 10.1038/ejcn.2010.194 1:CAS:528:DC%2BC3MXht1Shtw%3D%3D
51. JD McKinney B Bailey L Garrett P Peiris T Manning AN Peiris 2011 Relationship between vitamin D Status and ICU outcomes in veterans J Am Med Dir Assoc 12 208 211 21333923 10.1016/j.jamda.2010.04.004
52. KK Braddy SN Imam KR Palla TA Lee 2009 Vitamin D deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis J Am Med Dir Assoc 10 653 657 19883889 10.1016/j.jamda.2009.08.010
53. AN Peiris BA Bailey T Manning L Adebonojo 2010 Are 25-hydroxyvitamin D levels adequately monitored following evidence of vitamin D insufficiency in veterans? Mil Med 175 453 456 20572480
54. WB Grant E Giovannucci 2009 The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States Dermatoendocrinol 1 215 219 20592793 10.4161/derm.1.4.9063 1:CAS:528:DC%2BD1MXhsFOqt7bI
55. WB Grant GE Schuitemaker 2010 Health benefits of higher serum 25-hydroxyvitamin D levels in The Netherlands J Steroid Biochem Mol Biol 121 456 458 20398763 10.1016/j.jsbmb.2010.03.089 1:CAS:528:DC%2BC3cXptVGjtrw%3D
56. DE Roth R Shah RE Black AH Baqui 2010 Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh Acta Paediatr 99 389 393 19900174 10.1111/j.1651-2227.2009.01594.x 1:CAS:528:DC%2BC3cXjvFGjsrk%3D
57. K Newens S Filteau A Tomkins 2006 Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection Trans R Soc Trop Med Hyg 100 41 44 16171835 10.1016/j.trstmh.2005.06.022 1:CAS:528:DC%2BD28XhvFansg%3D%3D (Pubitemid 41700188)
58. A Braun D Chang K Mahadevappa FK Gibbons Y Liu E Giovannucci KB Christopher 2011 Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill Crit Care Med 39 671 677 21242800 10.1097/CCM.0b013e318206ccdf 1:CAS:528:DC%2BC3MXjsVyrsrY%3D
59. D Youssef B Bailey A El Abbassi R Copeland L Adebonojo T Manning AN Manning 2010 Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency Epidemiol Infect 138 1322 1327 20056018 10.1017/S0950268809991543 1:CAS:528:DC%2BC3cXptlymsr4%3D
60. RN Jones 2001 Resistance patterns among nosocomial pathogens: trends over the past few years Chest 119 397S 404S 11171776 10.1378/chest.119.2-suppl.397S 1:CAS:528:DC%2BD3MXitFCis70%3D (Pubitemid 32163809)
61. JE Patterson 2001 Antibiotic utilization: is there an effect on antimicrobial resistance? Chest 119 426S 430S 11171780 10.1378/chest.119.2- suppl.426S 1:STN:280:DC%2BD3M7ltFSmug%3D%3D (Pubitemid 32163813)
62. MH Kollef G Sherman S Ward VJ Fraser 1999 Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 462 474 10027448 10.1378/chest.115.2.462 1:STN:280:DyaK1M7kvFKqtg%3D%3D (Pubitemid 29083057)
63. P Autier S Gandini 2007 Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials Arch Intern Med 167 1730 1737 17846391 10.1001/archinte.167.16.1730 1:CAS:528:DC%2BD2sXhtFejt7jN (Pubitemid 47403059)
64. WB Grant HS Cross CF Garland ED Gorham J Moan M Peterlik AC Porojnicu J Reichrath A Zittermann 2009 Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe Prog Biophys Mol Biol 99 104 113 19268496 10.1016/j.pbiomolbio.2009.02.003 1:CAS:528: DC%2BD1MXhtFagt7zP